| Company/Division name | Siemens Healthineers |
| Type of work | Manufacturing |
| If manufacturing, is the company an OEM? | Yes |
| Reshoring category: | Transplant |
| Total number of jobs (added or to be added): | 400 |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2016 |
| Year reshoring implemented or to be implemented: | 2026 |
| Offshore, work was done: | In-house |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 300 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Walpole |
| State(s) reshored to: | MA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | immunoassay instruments |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Impact on domestic economy |
| Government Incentive dollar amount: | 4.2 million |
